MYC and prostate carcinoma: Similarly, c-Myc activity and oncogenicity in prostate cancer can be attenuated by Akt phosphorylation in a redox dependent manner, but unlike the earlier studies this was linked to increased c-Myc proteolysis rather than transcriptional dysregulation [103].